Benzo(a)pyrene-induced genotoxicity: Attenuation by farnesol in a mouse model

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 23, Issue 6, 2008, Pages 888-894

  Jahangir, Tamanna ^a   Sultana, Sarwat ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

B(a)P; Benzo(a)pyrene; CytP450; DNA integrity, genotoxicity; Farnesol

Indexed keywords

ALCOHOL DERIVATIVE; BENZO[A]PYRENE; CARBON; CYTOCHROME P450; DNA; FARNESOL; GLUTATHIONE; GLUTATHIONE TRANSFERASE; ISOPRENOID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENUATION; CONTROLLED STUDY; DNA ADDUCT; DNA STRAND BREAKAGE; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME RELEASE; EXPERIMENTAL MODEL; GENOTOXICITY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; STRUCTURE ANALYSIS;

ANIMALS; BENZO(A)PYRENE; DNA ADDUCTS; DNA DAMAGE; FARNESOL; LIVER; MALE; MICE; MODELS, ANIMAL; MOLECULAR STRUCTURE;

EID: 56449103047     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360701448768     Document Type: Article

References (35)

1. Warshawsky, D. (1999) Polycyclic aromatic hydrocarbons in carcinogenesis. Environ mental Health Perspect, 107, pp. 317-319.
2. Arif, JM, Smith, WA and Gupta, RC (1999) DNA adduct formation and persistence in rat tissues following exposure to the mammary carcinogen dibenzo[a,l]pyrene. Carcinogenesis, 20, pp. 1147-1150.
3. Lightfoot, TJ, Coxhead, JM, Cupid, BC, Nicholson, S. and Garner, RC (2000) Analysis of DNA adducts by accelerator mass spectrometry in human breast tissue after administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and benzo[a]pyrene. Mutation Res, 472:1, pp. 119-127.
4. Khan, TH, Prasad, L. and Anuradha, Sultana S. (2005) Soy isoflavones inhibits the genotoxicity of benzo(a)pyrene in Swiss albino mice. Hum Exp Toxicol, 24:3, pp. 149-155.
5. Guengerich, FP (1988) Roles of cytochrome P450 enzymes in chemical carcinogenesis and cancer chemotherapy. Cancer Res, 48, pp. 2946-2954.
6. Szaefer, H., Cichocki, M., Brauze, D. and Baer-Dubowska, W. (2004) Alteration in phase I and II enzyme activities and polycyclic aromatic hydrocarbons-DNA adduct formation by plant phenolics in mouse epidermis. Nutrition Cancer, 48:1, pp. 70-77.
7. Sacchettini, JC and Poulter, CD (1997) Creating isoprenoid diversity. Science, 277, pp. 1788-1789.
8. Correll, CC, Ng, L. and Edwards, PA (1994) Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydrixy-3-methylglutaryl-coenzyme A reductase. J Biol Chem, 269, pp. 17390-17393.
9. Mo, H. and Elson, CE (1999) Apoptosis and cell-cycle arrest in human and murine tumor cells are initiated by isoprenoids. J Nutrit, 129, pp. 804-813.
10. Elson, CE and Yu, SG (1994) The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables. J Nutrit, 124, pp. 607-614.
11. Thomas L. Horn, Lina Long, Michael J. Cwik, Robert L. Morrissey, Izet M. Kapetanovic and David L. McCormick (2005) Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol. Chem-Biol Interac, 152, pp. 79-99.
12. Hanley, K., Komuves, LG, Ng, DC, Schoonjans, KS, He, SS, Lau, P., Bikle, DD, Williams, ML, Elias, PM, Auwerx, J. and Feingold, KR (2000) Farnesol stimulates differentiation in epidermal keratinocytes via PPARα. J Biol Chem, 275, pp. 11484-11491.
13. Adany, I., Yazlovitskaya, EM, Haug, JS, Voziyan, PA and Melnykovych G. (1994) Differences in sensitivity to farnesol toxicity between neoplastically- and non-neoplastically-derived cells in culture. Cancer Lett, 79, pp. 175-179.
14. Zhao, J., Nan, P. and Zhong, Y. (2004) Chemical composition of the essential oils of Clausena lansium from Hainan Island, China. Z Naturforsch [C], 59, pp. 153-156.
15. Forman, BM, Goode, E., Chen, J., Oro, AE, Bradley, DJ, Perlmann, T., Noonan, DJ, Burka, LT, McMorris, T., Lamph, WW, Evans, RM and Weinberger, C. (1995) Identification of a nuclear receptor that is activated by farnesol metabolites. Cell, 81, pp. 687-693.
16. Salamone, MF (1981) Toxicity of 41 carcinogens and noncarcinogenic analogs. Evaluation of short term tests for carcinogens. Report of the International Corroborative Program, pp. 682-685. Progress in Mutation Research, Elsevier North-Holland
17. Shugart, LR (1988) Quantitation of chemically induced damage to DNA of aquatic organisms by alkaline unwinding assay. Aquat Toxicol, 13, pp. 43-52.
18. Jahangir, T., Khan, TH, Prasad, L. and Sultana, S. (2005) Pluchea lanceolata attenuates cadmium chloride induced oxidative stress and genotoxicity in Swiss albino mice. J Pharm Pharmacol, 57:9, pp. 1199-1204.
19. Xu, L., Zheng, GJ, Lam, PKS and Richardson, B. (1999) Relationship between tissue concentrations of polycyclic aromatic hydrocarbons and DNA adducts in green-lipped mussels(Perna viridis). Ecotoxicol, 8, pp. 73-82.
20. Rao, SS, Neheli, TA and Carey, JH (1996) DNA alkaline unwinding assay for monitoring the impact of environmental genotoxins. Environ Toxicol Water Qual, 11, pp. 351-354.
21. Weibel, FL and Gelboin, HV (1975) Arylhydrocarbon benzo(a)pyrene hydroxylase in liver from rat of different age, sex and nutritional status. Biochem Pharmacol, 24, pp. 1511-1515.
22. Omura, T. and Sato, R. (1964) The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem, 239, pp. 2370-2378.
23. Habig, WH, Pubst, MJ and Jokoby, WB (1974) GST the first enzymatic step in mercapturic acid formation. J Biol Chem, 249, pp. 7130-7139.
24. Benson, AM, Hunkeler, MJ and Talalay, P. (1980) Increase of NADPH; Quinone reductase activity by dietary antioxidant. Possible role in protection against carcinogenesis and toxicity. Proc Nat Acad Sci USA, 77, pp. 5216-5220.
25. Jollow, DJ, Mitchell, JR, Zampaglione, N. and Gillette, JR (1974) Bromobenzene induced liver necrosis: Protective role of glutathione and evidence for 3,4-bromobezene oxide as the hepatotoxic metabolite. Pharmacol, 11, p. 151.
26. Lowry, OH, Rosebrough, NJ, Farr, AL and Randall, RJ (1964) Protein measurement with the phenol reagent. J Biol Chem, 193, pp. 2370-2378.
27. Phillips, DH (1999) Polycyclic aromatic hydrocarbons in the diet. Mutation Res, 443, pp. 139-147.
28. Garner, RC (1998) The role of DNA adducts in chemical carcinogenesis. Mutation Res, 402, pp. 67-75.
29. Prochaska, HJ and Talalay, P. (1988) Regulatory mechanisms of monofunctional and bifunctional anticarcinogenic enzyme inducers in murine liver. Cancer Res, 48, pp. 4776-4782.
30. Wattenberg, LW (1997) An overview of chemoprevention: Current status and future prospects. Proc Soc Exper Biol Med, 216, pp. 133-141.
31. Sparnins, VL, Venegas, PL and Wattenberg, LW (1982) Glutathione-S-transferase activity: Enhancement by compounds inhibiting chemical carcinogenesis and by dietary constituents. J Nat Cancer Inst, 68, pp. 493-496.
32. Haug, JS, Goldner, CM, Yazlovitskaya, EM, Voziyan, PA and Melnykovych, G. (1994) Directed cell killing (apoptosis) in human lymphoblastoid cells incubated in the presence of farnesol: Effect of phosphatidylcholine. Biochem Biophys Acta, 1223, pp. 133-140.
33. Burke, YD, Stark, MJ, Roach, SL, Sen, SE and Crowell, PL (1997) Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids, 32, pp. 151-156.
34. Zunino, F., Pratesi, G., Micheloni, A., Cavalletti, E., Sala, F. and Tofanetti, O. (1989) Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. Chem-Biol Interact, 70:1, pp. 89-101.
35. Doudican, NA, Song, B., Shadel, GS, Doetsch, PW and Oxidative, DNA (2005) damage causes mitochondrial genomic instability in Saccharomyces cerevisiae. Mol Cell Biol, 25, pp. 5196-5204.